{"id":"NCT01442038","sponsor":"Gilead Sciences","briefTitle":"Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2011-09-28","resultsPosted":"2016-07-15","lastUpdate":"2016-07-15"},"enrollment":2651,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Coronary Artery Disease","Angina Pectoris"],"interventions":[{"type":"DRUG","name":"Ranolazine","otherNames":["Ranexa"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ranolazine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the efficacy of ranolazine as compared with placebo when used as part of standard medical therapy in chronic angina subjects with incomplete revascularization post-percutaneous coronary intervention (PCI; formerly known as angioplasty with stent) on the composite of ischemia-driven revascularization or ischemia-driven hospitalization without revascularization.","primaryOutcome":{"measure":"Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without Revascularization","timeFrame":"Baseline through end of study (average 90 weeks)","effectByArm":[{"arm":"Ranolazine","deltaMin":3.4,"sd":null},{"arm":"Placebo","deltaMin":2.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.48"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":218,"countries":["United States","Austria","Belgium","Canada","Czechia","France","Germany","Israel","Italy","Netherlands","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["24268208","26474810","26555329","30771861"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":516,"n":1322},"commonTop":["Dizziness","Angina pectoris","Constipation","Chest pain","Headache"]}}